Cogent Biosciences, Inc. (NASDAQ:COGT) is one of the 11 Best Performing Stocks in the Last 12 Months. On January 26, 2026, ...
Learn how radiopharmaceuticals are transforming cancer treatment and creating new opportunities for biotech and pharma companies.
FDA feedback focused on dosing and testing questions, not safety or effectiveness concerns. ・Joenja’s existing approval and sales in patients aged 12 and older remain unchanged. ・Pharming said it ...